Home / E2F1 Knockout Cell Lines

E2F1 Knockout Cell Lines

Gene: E2F1

Official Full Name: E2F transcription factor 1provided by HGNC

Gene Summary: The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO09264 E2F1 Knockout cell line (HeLa) Human E2F1 1:3~1:6 Negative Online Inquiry
KO09265 E2F1 Knockout cell line (HCT 116) Human E2F1 1:2~1:4 Negative Online Inquiry
KO09266 E2F1 Knockout cell line (HEK293) Human E2F1 1:3~1:6 Negative Online Inquiry
KO09267 E2F1 Knockout cell line (A549) Human E2F1 1:3~1:4 Negative Online Inquiry

Background

E2F1 Gene Knockout Cell Lines are genetically engineered cell lines in which the E2F1 gene, a critical regulator of the cell cycle and transcription, has been inactivated. E2F1 plays a pivotal role in controlling key cellular processes such as proliferation, differentiation, and apoptosis by influencing the transition from the G1 to the S phase of the cell cycle. By knocking out this gene, researchers can investigate the molecular underpinnings of cell cycle regulation and its implications in cancer biology, as dysregulation of E2F1 has been implicated in various malignancies.

The mechanisms through which E2F1 influences cellular functions include its ability to interact with other proteins, such as retinoblastoma (Rb) tumor suppressor, which modulates the transcription of downstream target genes necessary for DNA synthesis. The E2F1 Gene Knockout Cell Lines provide an invaluable tool for examining these interactions and assessing the downstream effects of E2F1 loss on cellular behavior, gene expression, and metabolic pathways.

In research and clinical settings, E2F1 knockout models facilitate advancements in cancer therapeutics by aiding in the validation of targeted treatment strategies. They allow for a more nuanced understanding of tumor biology, including resistance mechanisms and the identification of novel biomarkers associated with cancer progression.

Compared to traditional methods of gene silencing, E2F1 Gene Knockout Cell Lines offer a more stable and permanent loss of function, thereby avoiding transient effects that may confound experimental results. The specificity and reliability of these knockout models enhance the robustness of experimental findings, making them indispensable for academic and pharmaceutical research.

For researchers and clinicians focused on cell cycle regulation, oncogenic pathway elucidation, and therapeutic drug development, E2F1 Gene Knockout Cell Lines represent a crucial asset. Our commitment to innovation and quality in biological products ensures that you receive the most reliable tools to advance your scientific endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.